92 related articles for article (PubMed ID: 3069842)
21. Synthesis and biological evaluation of phosphonamidate peptide inhibitors of enkephalinase and angiotensin-converting enzyme.
Elliott RL; Marks N; Berg MJ; Portoghese PS
J Med Chem; 1985 Sep; 28(9):1208-16. PubMed ID: 2993614
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of the analgesic neuropeptides kyotorphin and neo-kyotorphin on enkephalin-degrading enzymes from monkey brain.
Hazato T; Kase R; Ueda H; Takagi H; Katayama T
Biochem Int; 1986 Mar; 12(3):379-83. PubMed ID: 3011001
[TBL] [Abstract][Full Text] [Related]
23. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
[TBL] [Abstract][Full Text] [Related]
24. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme].
Roques BP
J Pharmacol; 1985; 16 Suppl 1():5-31. PubMed ID: 2993752
[TBL] [Abstract][Full Text] [Related]
25. New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity, and analgesic properties.
Fournié-Zaluski MC; Chaillet P; Soroca-Lucas E; Marçais-Collado H; Costentin J; Roques BP
J Med Chem; 1983 Jan; 26(1):60-5. PubMed ID: 6298420
[TBL] [Abstract][Full Text] [Related]
26. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
[TBL] [Abstract][Full Text] [Related]
27. Glutamic acid analogues as potent dipeptidyl peptidase IV and 8 inhibitors.
Lu IL; Lee SJ; Tsu H; Wu SY; Kao KH; Chien CH; Chang YY; Chen YS; Cheng JH; Chang CN; Chen TW; Chang SP; Chen X; Jiaang WT
Bioorg Med Chem Lett; 2005 Jul; 15(13):3271-5. PubMed ID: 15927466
[TBL] [Abstract][Full Text] [Related]
28. Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action.
Fournie-Zaluski MC; Coric P; Thery V; Gonzalez W; Meudal H; Turcaud S; Michel JB; Roques BP
J Med Chem; 1996 Jun; 39(13):2594-608. PubMed ID: 8691458
[TBL] [Abstract][Full Text] [Related]
29. 1H NMR configurational correlation for retro-inverso dipeptides: application to the determination of the absolute configuration of "enkephalinase" inhibitors. Relationships between stereochemistry and enzyme recognition.
Fournié-Zaluski MC; Lucas-Soroca E; Devin J; Roques BP
J Med Chem; 1986 May; 29(5):751-7. PubMed ID: 3517331
[TBL] [Abstract][Full Text] [Related]
30. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.
Coric P; Turcaud S; Meudal H; Roques BP; Fournie-Zaluski MC
J Med Chem; 1996 Mar; 39(6):1210-9. PubMed ID: 8632427
[TBL] [Abstract][Full Text] [Related]
31. The specificity of prolyl endopeptidase from Flavobacterium meningoseptum: mapping the S' subsites by positional scanning via acyl transfer.
Bordusa F; Jakubke HD
Bioorg Med Chem; 1998 Oct; 6(10):1775-80. PubMed ID: 9839007
[TBL] [Abstract][Full Text] [Related]
32. Isolation of propioxatin A from Actinosynnema sp. SI-23 during a screening for Serratia piscatorum metalloproteinase inhibitors.
Murao S; Imafuku S; Oyama H
Biosci Biotechnol Biochem; 1997 Mar; 61(3):561-2. PubMed ID: 9095561
[TBL] [Abstract][Full Text] [Related]
33. Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril.
Gros C; Noël N; Souque A; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Lecomte JM; Bralet J
Proc Natl Acad Sci U S A; 1991 May; 88(10):4210-4. PubMed ID: 1851998
[TBL] [Abstract][Full Text] [Related]
34. Subsite specificity (S3, S2, S1', S2' and S3') of oligopeptidase B from Trypanosoma cruzi and Trypanosoma brucei using fluorescent quenched peptides: comparative study and identification of specific carboxypeptidase activity.
Hemerly JP; Oliveira V; Del Nery E; Morty RE; Andrews NW; Juliano MA; Juliano L
Biochem J; 2003 Aug; 373(Pt 3):933-9. PubMed ID: 12737623
[TBL] [Abstract][Full Text] [Related]
35. Effect of electron withdrawing substituents on substrate hydrolysis by and inhibition of rat neutral endopeptidase 24.11 (enkephalinase) and thermolysin.
Bateman RC; Rodriguez G; Vijayaraghavan J; Hersh LB
Arch Biochem Biophys; 1990 Jun; 279(2):355-62. PubMed ID: 2350181
[TBL] [Abstract][Full Text] [Related]
36. Evidence that Asn542 of neprilysin (EC 3.4.24.11) is involved in binding of the P2' residue of substrates and inhibitors.
Dion N; Le Moual H; Fournié-Zaluski MC; Roques BP; Crine P; Boileau G
Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):623-7. PubMed ID: 7487905
[TBL] [Abstract][Full Text] [Related]
37. A novel class of enkephalinase inhibitors containing a C-terminal sulfo group.
Mimura T; Nakamura Y; Nishino J; Sawayama T; Komiya T; Deguchi T; Kita A; Nakamura H; Matsumoto J
J Med Chem; 1992 Feb; 35(3):602-8. PubMed ID: 1738153
[TBL] [Abstract][Full Text] [Related]
38. Enkephalinase: selective inhibitors and partial characterization.
Sullivan S; Akil H; Blacker D; Barchas JD
Peptides; 1980; 1(1):31-5. PubMed ID: 6264406
[TBL] [Abstract][Full Text] [Related]
39. Novel amidino-substituted benzimidazoles: synthesis of compounds and inhibition of dipeptidyl peptidase III.
Agić D; Hranjec M; Jajcanin N; Starcević K; Karminski-Zamola G; Abramić M
Bioorg Chem; 2007 Apr; 35(2):153-69. PubMed ID: 17174378
[TBL] [Abstract][Full Text] [Related]
40. Effect of several amino acid phosphonates and other compounds on rat brain and kidney peptidases.
Weiss B; Hui KS; Benuck M; Hui M; Berg MJ; Lajtha A
Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):81-92. PubMed ID: 3520730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
